|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00660 WAI CHUN BIOTEC
Nominal 
0.074 0.000 (0.000%) | 2023/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 190,330 | -53.014% | 773,654 | 1,007,186 | 567,553 | 579,231 |
| Cost of Sales | (173,535) | -54.138% | (723,241) | (917,001) | (518,623) | (530,204) |
| Gross Profit | 16,795 | -37.076% | 50,413 | 90,185 | 48,930 | 49,027 |
| 2023/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | (2,282) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | 67 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (2,845) | -24.716% | (5,698) | 3,777 | 1,611 | 9,063 | |
| Taxation | (1,185) | -22.498% | (4,364) | (5,167) | (616) | (75) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (2,704) | 7.174% | (5,371) | (20,155) | (9,144) | (12,147) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (6,734) | -14.008% | (15,433) | (21,545) | (8,149) | (3,159) | |
| 2023/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | 8,829 | 4.808% | 17,076 | 20,924 | 7,889 | 5,816 |
| Depreciation & Amortisation | 5,650 | 7.272% | 14,062 | 16,198 | 6,375 | 5,333 |
| Directors' Emoluments | -- | -- | 1,549 | 4,737 | 2,760 | 1,719 |
| 2023/12 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) |
Market Valuation Indicators
| 2023/12 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2020/12 | 2019/12 | |
| EPS (cts) | -3.930 | -14.004% | -9.100 | -12.900 | -4.900 | -1.900 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.290 | 0.029 | (0.002) | 0.009 |
| NBV per share ($) | (0.227) | -- | (0.204) | (0.224) | (0.226) | (0.303279) |
| Remarks: | Real time quote last updated: 28/11/2024 11:07 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -6,734,000 |
| %Change | -14.008% |
| EPS / (LPS) | HKD -0.039 |
| NBV Per Share ($) | HKD -0.227 |